TALPHERA, INC. (TLPH)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch TLPH
See up to 3 months of TLPH. The 7-day demo opens the 1M and 3M ranges and puts TLPH on your watchlist.
Start 7-day demoLatest TLPH insider trades
About TALPHERA, INC. (TLPH)
The SEC lists TALPHERA, INC. under CIK 0001427925, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
TLPH Form 4 activity by transaction type, last 90 days
No Form 4 activity for TLPH in the last 90 days.
TLPH insider transactions (Form 4)
5228 Form 4 filings on record, the earliest from Dec 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark A. Wan | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| Mark A. Wan | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| ||||||
| Joseph Todisco | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| Joseph Todisco | Grant or award | Director Stock Option (right to buy) | 30,700 | $0.00 | - | |
| ||||||
| Abhinav Jain | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| Abhinav Jain | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| ||||||
| Stephen J. Hoffman | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| Stephen J. Hoffman | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| ||||||
| Jill Marie Broadfoot | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| Jill Marie Broadfoot | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| ||||||
| Marina Bozilenko | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| Marina Bozilenko | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| ||||||
| Adrian Adams | Grant or award | Common Stock | 5,100 footnote F2 | $0.00 | - | |
| Adrian Adams | Grant or award | Stock Option (Right to Buy) | 30,700 | $0.00 | - | |
| ||||||
 Shakil Aslam - Officer | Tax withholding / forfeiture | Common Stock | 4,518 footnote F1 | $0.82 | $4K | |
| ||||||
| Vincent J. Angotti - Officer | Tax withholding / forfeiture | Common Stock | 9,938 footnote F1 | $0.72 | $7K | |
| ||||||
| Raffi Asadorian - Officer | Tax withholding / forfeiture | Common Stock | 2,444 footnote F1 | $0.72 | $2K | |
| ||||||
| Shakil Aslam - Officer | Tax withholding / forfeiture | Common Stock | 2,118 footnote F1 | $0.72 | $2K | |
| ||||||
 Badri N. Dasu - Officer | Tax withholding / forfeiture | Common Stock | 2,444 footnote F1 | $0.72 | $2K | |
| ||||||
| Vincent J. Angotti - Officer | Open-market purchase | Common Stock | 213,310 footnote F1 | $0.59 | $125K | |
| ||||||
| Nantahala Capital Management, LLC - 10% Owner | Grant or award | Pre-Funded Warrants | 4,266,211 | $0.59 | $2.50M | |
| Vincent J. Angotti - Officer | Tax withholding / forfeiture | Common Stock | 3,179 footnote F1 | $0.84 | $3K | |
| Vincent J. Angotti - Officer | Open-market purchase | Common Stock | 105,364 footnote F3 | $0.81 | $86K | |
| Vincent J. Angotti - Officer | Tax withholding / forfeiture | Common Stock | 9,559 footnote F1 | $0.79 | $8K | |
| Vincent J. Angotti - Officer | Grant or award | Stock Option (Right to Buy) | 594,000 | $0.00 | - | |
| ||||||
| Shakil Aslam - Officer | Open-market purchase | Common Stock | 35,000 footnote F1 | $0.81 | $28K | |
| Shakil Aslam - Officer | Grant or award | Stock Option (Right to Buy) | 205,000 | $0.00 | - | |
| ||||||
| Badri N. Dasu - Officer | Tax withholding / forfeiture | Common Stock | 781 footnote F1 | $0.84 | $653 | |
| Badri N. Dasu - Officer | Open-market purchase | Common Stock | 35,000 footnote F2 | $0.81 | $28K | |
| Badri N. Dasu - Officer | Tax withholding / forfeiture | Common Stock | 2,346 footnote F1 | $0.79 | $2K | |
| Badri N. Dasu - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| ||||||
| Raffi Asadorian - Officer | Tax withholding / forfeiture | Common Stock | 958 footnote F1 | $0.84 | $801 | |
| Raffi Asadorian - Officer | Open-market purchase | Commom Stock | 45,000 footnote F2 | $0.81 | $37K | |
| Raffi Asadorian - Officer | Tax withholding / forfeiture | Common Stock | 2,933 footnote F1 | $0.79 | $2K | |
| Raffi Asadorian - Officer | Grant or award | Stock Option (Right to Buy) | 260,000 | $0.00 | - | |
| ||||||
| Abhinav Jain | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| Abhinav Jain | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| ||||||
| Marina Bozilenko | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| Marina Bozilenko | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| ||||||
| Jill Marie Broadfoot | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| Jill Marie Broadfoot | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| ||||||
| Adrian Adams | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| Adrian Adams | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| ||||||
| Mark A. Wan | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| Mark A. Wan | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| ||||||
| Stephen J. Hoffman | Grant or award | Common Stock | 4,267 footnote F2 | $0.00 | - | |
| Stephen J. Hoffman | Grant or award | Stock Option (Right to Buy) | 25,600 | $0.00 | - | |
| ||||||
| Joseph Todisco | Grant or award | Common Stock | 6,397 footnote F2 | $0.00 | - | |
| Joseph Todisco | Grant or award | Director Stock Option (right to buy) | 38,381 | $0.00 | - | |
| ||||||
| Vincent J. Angotti - Officer | Open-market purchase | Common Stock | 5,000 | $0.64 | $3K | |
| Raffi Asadorian - Officer | Open-market sale | Common Stock | 155 | $0.77 | $119 | |
| Vincent J. Angotti - Officer | Open-market purchase | Common Stock | 5,000 | $0.73 | $4K | |
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
TLPH insider trading FAQ
What is the latest insider trade for TLPH?
TALPHERA, INC. (TLPH) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-24. The full record for TLPH runs to 28 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TLPH stock?
No insider purchases of TLPH were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling TLPH stock?
No insider sales of TLPH were filed in the last 90 days. 1 sale is on record for this company.
Where can I see TLPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TLPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark A. Wan view on EDGAR
- - Joseph Todisco view on EDGAR
- - Abhinav Jain view on EDGAR
- - Stephen J. Hoffman view on EDGAR
- - Jill Marie Broadfoot view on EDGAR
- - Marina Bozilenko view on EDGAR
- - Adrian Adams view on EDGAR
- - Shakil Aslam view on EDGAR
- - Vincent J. Angotti view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TLPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TLPH with a 7-day demo
- TLPH on your watchlist
- Every TLPH Form 4 filing on record
- Up to 3 months of TLPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
